These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 18930555)

  • 1. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use.
    Fraunfelder FW; Richards AB
    Ophthalmology; 2008 Dec; 115(12):2282-5. PubMed ID: 18930555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diplopia and fluoroquinolones.
    Fraunfelder FW; Fraunfelder FT
    Ophthalmology; 2009 Sep; 116(9):1814-7. PubMed ID: 19643481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral uveitis associated with fluoroquinolone therapy.
    Hinkle DM; Dacey MS; Mandelcorn E; Kalyani P; Mauro J; Bates JH; Soukasian SH; Holland GN; Foster CS; Fraunfelder FT; Davis JL; Fraunfelder FW
    Cutan Ocul Toxicol; 2012 Jun; 31(2):111-6. PubMed ID: 21981449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin-associated adverse cognitive effects: survey results from 171 patients.
    Evans MA; Golomb BA
    Pharmacotherapy; 2009 Jul; 29(7):800-11. PubMed ID: 19558254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system.
    Colman E; Szarfman A; Wyeth J; Mosholder A; Jillapalli D; Levine J; Avigan M
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1068-76. PubMed ID: 18821724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.
    McAdams M; Staffa J; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):229-39. PubMed ID: 18175291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular side effects from herbal medicines and nutritional supplements.
    Fraunfelder FW
    Am J Ophthalmol; 2004 Oct; 138(4):639-47. PubMed ID: 15488795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular hemorrhage possibly the result of HMG-CoA reductase inhibitors.
    Fraunfelder FW
    J Ocul Pharmacol Ther; 2004 Apr; 20(2):179-82. PubMed ID: 15117574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
    Jones PH; Davidson MH
    Am J Cardiol; 2005 Jan; 95(1):120-2. PubMed ID: 15619408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-CoA-reductase inhibitors and neuropathy: reports to the Netherlands Pharmacovigilance Centre.
    de Langen JJ; van Puijenbroek EP
    Neth J Med; 2006 Oct; 64(9):334-8. PubMed ID: 17057271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin safety: an appraisal from the adverse event reporting system.
    Davidson MH; Clark JA; Glass LM; Kanumalla A
    Am J Cardiol; 2006 Apr; 97(8A):32C-43C. PubMed ID: 16581327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Statins--the pattern of adverse effects with empahsis on mental reactions. Data from a national and an international database].
    Buajordet I; Madsen S; Olsen H
    Tidsskr Nor Laegeforen; 1997 Sep; 117(22):3210-3. PubMed ID: 9411859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins, cardiovascular disease, and drug safety.
    Gotto AM
    Am J Cardiol; 2006 Apr; 97(8A):3C-5C. PubMed ID: 16581326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between statin use and lupus-like syndrome using spontaneous reports.
    de Jong HJ; Tervaert JW; Saldi SR; Vandebriel RJ; Souverein PC; Meyboom RH; van Loveren H; Klungel OH
    Semin Arthritis Rheum; 2011 Dec; 41(3):373-81. PubMed ID: 21868063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blepharoptosis and external ophthalmoplegia associated with long-term antiretroviral therapy.
    Dinges WL; Witherspoon SR; Itani KM; Garg A; Peterson DM
    Clin Infect Dis; 2008 Sep; 47(6):845-52. PubMed ID: 18687051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin-associated ocular disorders: the FDA and ADRAC data.
    Mizranita V; Pratisto EH
    Int J Clin Pharm; 2015 Oct; 37(5):844-50. PubMed ID: 25939673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding indications for statins in cerebral ischemia: a quantitative study.
    Ovbiagele B; Kidwell CS; Saver JL
    Arch Neurol; 2005 Jan; 62(1):67-72. PubMed ID: 15642851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports.
    Fraunfelder FW; Suhler EB; Fraunfelder FT
    Cutan Ocul Toxicol; 2010 Mar; 29(1):26-9. PubMed ID: 19947819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Concomitant use of statins and cytochrome P 450 inhibitors in Croatia].
    Reiner Z; Galić M; Hanzevacki M; Tedeschi-Reiner E
    Lijec Vjesn; 2005; 127(3-4):65-8. PubMed ID: 16193855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.